Article Text

Download PDFPDF

Eczema and subsequent suicide: a matched case–control study
  1. Aaron Mark Drucker1,2,3,
  2. Deva Thiruchelvam4,
  3. Donald A Redelmeier4,5,6,7
  1. 1 Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  2. 2 Division of Dermatology, Department of Medicine, Women’s College Hospital, Toronto, Ontario, Canada
  3. 3 Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada
  4. 4 Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
  5. 5 Division of General Internal Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
  6. 6 Evaluative Clinical Science Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada
  7. 7 Center for Leading Injury Prevention Practice Education & Research, Toronto, Ontario, Canada
  1. Correspondence to Dr Aaron Mark Drucker; aaron.drucker{at}wchospital.ca

Footnotes

  • Contributors AMD and DAR designed and obtained funding for the study. DT performed data analysis. AMD drafted the manuscript and all authors contributed to critical revision of the manuscript. DAR accepts full responsibility for the work, the conduct of the study, had access to the data, and the decision to publish. AMD attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

  • Funding This study was supported in part by research grants from the National Eczema Association and Eczema Society of Canada. DAR receives funding from the Government of Canada through a Canada Research Chair in Medical Decision Sciences. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.

  • Disclaimer The funders had no role in the design, conduct or decision to publish this study. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources.

  • Competing interests AMD served as an investigator and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada and the Canadian Agency for Drugs and Technologies in Health. He has received honoraria from Astellas Canada, Prime, Spire Learning, CME Outfitters and Eczema Society of Canada.

  • Patient consent Not required.

  • Ethics approval The study was approved by the Institute for Clinical Evaluative Sciences (ICES) and the Women’s College Hospital Research Ethics Board deemed the work exempt from supplementary ethics review.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement There is no plan to share raw data from this study.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors AMD and DAR designed and obtained funding for the study. DT performed data analysis. AMD drafted the manuscript and all authors contributed to critical revision of the manuscript. DAR accepts full responsibility for the work, the conduct of the study, had access to the data, and the decision to publish. AMD attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

  • Funding This study was supported in part by research grants from the National Eczema Association and Eczema Society of Canada. DAR receives funding from the Government of Canada through a Canada Research Chair in Medical Decision Sciences. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.

  • Disclaimer The funders had no role in the design, conduct or decision to publish this study. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources.

  • Competing interests AMD served as an investigator and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada and the Canadian Agency for Drugs and Technologies in Health. He has received honoraria from Astellas Canada, Prime, Spire Learning, CME Outfitters and Eczema Society of Canada.

  • Patient consent Not required.

  • Ethics approval The study was approved by the Institute for Clinical Evaluative Sciences (ICES) and the Women’s College Hospital Research Ethics Board deemed the work exempt from supplementary ethics review.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement There is no plan to share raw data from this study.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.